2 Biotech Firms Join IPO Fray With Plans To Raise $211M
By Tom Zanki · January 29, 2024, 4:56 PM EST
Two drug developers, metabolism-focused Fractyl Health Inc. and psychiatry-focused Alto NeuroScience Inc., joined a growing pipeline of initial public offerings Monday by unveiling plans for IPOs that could net $211 million...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login